BV3 Stock Price and Chart — TRADEGATE:BV3

Overview

About BAVARIAN NORDIC A/S

Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.

Financials

Performance

Revenue to profit conversion

Debt level and coverage

Earnings

Next:—

Ideas

See all ideas

An aggregate view of professional's ratings.

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Seasonals

Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as BV3.

Depending on the exchange, the stock ticker may vary. For instance, on TRADEGATE exchange BAVARIAN NORDIC stocks are traded under the ticker BV3.

We've gathered analysts' opinions on BAVARIAN NORDIC future price: according to them, BV3 price has a max estimate of 40.18 EUR and a min estimate of 30.94 EUR. Watch BV3 chart and read a more detailed BAVARIAN NORDIC stock forecast: see what analysts think of BAVARIAN NORDIC and suggest that you do with its stocks.

BV3 reached its all-time high on Aug 4, 2022 with the price of 56.440 EUR, and its all-time low was 14.070 EUR and was reached on Apr 1, 2020. View more price dynamics on BV3 chart.
See other stocks reaching their highest and lowest prices.

Yes, you can track BAVARIAN NORDIC financials in yearly and quarterly reports right on TradingView.

BAVARIAN NORDIC is going to release the next earnings report on May 9, 2025. Keep track of upcoming events with our Earnings Calendar.

BAVARIAN NORDIC revenue for the last quarter amounts to ‪279.95 M‬ EUR, despite the estimated figure of ‪250.27 M‬ EUR. In the next quarter, revenue is expected to reach ‪125.90 M‬ EUR.

BV3 net income for the last quarter is ‪103.05 M‬ EUR, while the quarter before that showed ‪9.45 M‬ EUR of net income which accounts for 990.69% change. Track more BAVARIAN NORDIC financial stats to get the full picture.

No, BV3 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

As of Apr 25, 2025, the company has ‪1.61 K‬ employees. See our rating of the largest employees — is BAVARIAN NORDIC on this list?

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BAVARIAN NORDIC EBITDA is ‪215.47 M‬ EUR, and current EBITDA margin is 27.30%. See more stats in BAVARIAN NORDIC financial statements.

Like other stocks, BV3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BAVARIAN NORDIC stock right from TradingView charts — choose your broker and connect to your account.